Showing results 1 to 20 of 73
next >
| Preview | Issue Date | Title | Author(s) |
| 2004 | A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA: Potential role in mRNA stabilization | Coles, L.; Bartley, M.; Bert, A.; Hunter, J.; Polyak, S.; Diamond, P.; Vadas, M.; Goodall, G. |
| 2002 | A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts | Coles, L.; Diamond, P.; Lambrusco, L.; Hunter, J.; Burrows, J.; Vadas, M.; Goodall, G. |
| 2000 | A phase 1 study of the GM-CSF antagonist E21R | Olver, I.; Vadas, M.; Lopez, A.; Keefe, D.; Taylor, A.; Brown, M.; To, L.; ASCO - Volume 19 2000 |
| 2002 | A phase I study of the GM-CSF antagonist E21R | Olver, I.; Hercus, T.; Lopez, A.; Vadas, M.; Somogyi, A.; Doyle, I.; Foster, D.; Keefe, D.; Taylor, A.; Brown, M.; To, L.; Cole, J.; Rawling, T.; Cambareri, B.; Myers, M.; Olszewski, N.; Bastiras, S.; Senn, C.; Hey, A.; Verma, M.; et al. |
| 2001 | A point mutant of human sphingosine kinase 1 with increased catalytic activity | Pitson, S.; Moretti, P.; Zebol, J.; Vadas, M.; D'Andrea, R.; Wattenberg, B. |
| 2010 | A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration | Williams, S.; Milne, I.; Bagley, C.; Gamble, J.; Vadas, M.; Pitson, S.; Khew-Goodall, Y. |
| 1998 | A splice-isoform of vesicle-associated membrane protein-1 (VAMP-1) contains a mitochondrial targeting signal | Isenmann, S.; Khew-Goodall, Y.; Gamble, J.; Vadas, M.; Wattenberg, B. |
| 2004 | A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis | Su, Z.; Hahn, C.; Goodall, G.; Reck, N.; Leske, A.; Davy, A.; Kremmidiotis, G.; Vadas, M.; Gamble, J. |
| 2003 | Activation of endothelial extracellular signal-regulated kinase is essential for neutrophil transmigration: Potential involvement of a soluble neutrophil factor in endothelial activation | Stein, B.; Gamble, J.; Pitson, S.; Vadas, M.; Khew-Goodall, Y. |
| 2003 | Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation | Pitson, S.; Moretti, P.; Zebol, J.; Lynn, H.; Xia, P.; Vadas, M.; Wattenberg, B. |
| 2005 | Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells | Wang, L.; Xing, X.; Holmes, A.; Wadham, C.; Gamble, J.; Vadas, M.; Xia, P. |
| 2004 | An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes | Roberts, J.; Moretti, P.; Darrow, A.; Derian, C.; Vadas, M.; Pitson, S. |
| 2000 | An oncogenic role of sphingosine kinase | Xia, P.; Gamble, J.; Wang, L.; Pitson, S.; Moretti, P.; Wattenberg, B.; D'Andrea, R.; Vadas, M. |
| 2000 | An ordered array of cold shock domain repressor elements across tumor necrosis factor-responsive elements of the granulocyte-macrophage colony-stimulating factor promoter | Coles, L.; Diamond, P.; Occhiodoro, F.; Vadas, M.; Shannon, M. |
| 2006 | Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs | Bert, A.; Grepin, R.; Vadas, M.; Goodall, G. |
| 2008 | Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1 | Li, X.; Stankovic, M.; Bonder, C.; Hahn, C.; Parsons, M.; Pitson, S.; Xia, P.; Proia, R.; Vadas, M.; Gamble, J. |
| 2009 | Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells | Limaye, V.; Xia, P.; Hahn, C.; Smith, M.; Vadas, M.; Pitson, S.; Gamble, J. |
| 1999 | Cloning, characterization, and chromosomal location of a novel human K+-C1- cotransporter | Hiki, K.; D'Andrea, R.; Furze, J.; Crawford, J.; Woollatt, E.; Sutherland, G.; Vadas, M.; Gamble, J. |
| 2001 | Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cells | Diamond, P.; Shannon, M.; Vadas, M.; Coles, L. |
| 1998 | Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common β chain in transgenic mice | D'Andrea, R.; Harrison-Findik, D.; Butcher, C.; Finnie, J.; Blumbergs, P.; Bartley, P.; McCormack, M.; Jones, K.; Rowland, R.; Gonda, T.; Vadas, M. |
